Viking Therapeutics Inc VKTX:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
Last | 9:45 AM EDT
75.12quote price arrow down-1.31 (-1.71%)
Volume
168,115
52 week range
8.28 - 99.41
Loading...
  • Open78.13
  • Day High78.13
  • Day Low74.70
  • Prev Close76.43
  • 52 Week High99.41
  • 52 Week High Date02/28/24
  • 52 Week Low8.28
  • 52 Week Low Date10/26/23

Key Stats

  • Market Cap8.283B
  • Shares Out110.27M
  • 10 Day Average Volume2.94M
  • Dividend-
  • Dividend Yield-
  • Beta1.12
  • YTD % Change310.69

KEY STATS

  • Open78.13
  • Day High78.13
  • Day Low74.70
  • Prev Close76.43
  • 52 Week High99.41
  • 52 Week High Date02/28/24
  • 52 Week Low8.28
  • 52 Week Low Date10/26/23
  • Market Cap8.283B
  • Shares Out110.27M
  • 10 Day Average Volume2.94M
  • Dividend-
  • Dividend Yield-
  • Beta1.12
  • YTD % Change310.69

RATIOS/PROFITABILITY

  • EPS (TTM)-0.93
  • P/E (TTM)-80.73
  • Fwd P/E (NTM)-67.61
  • EBITDA (TTM)-114.363M
  • ROE (TTM)-17.55%
  • Revenue (TTM)-
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date07/24/2024(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Viking Therapeutics Inc

Profile

MORE
Viking Therapeutics, Inc. is a clinical-stage biopharmaceutical company that is focused on the development of therapies for treatment of metabolic and endocrine disorders. The Company's clinical programs include VK2809, an orally available, small molecule selective thyroid hormone receptor beta agonist for the treatment of lipid and metabolic disorders, which is being evaluated in a Phase II b study for the treatment of biopsy-confirmed non-alcoholic steatohepatitis (NASH)...
Lawson Macartney Ph.D.
Independent Chairman of the Board
Brian Lian Ph.D.
President, Chief Executive Officer, Director
Marianne Mancini
Chief Operating Officer
Greg Zante CPA
Chief Financial Officer
Address
9920 Pacific Heights Blvd, Suite 350
San Diego, CA
92121
United States

Top Peers

SYMBOLLASTCHG%CHG
CERE
Cerevel Therapeutics Holdings Inc
42.60-0.03-0.07%
ROIV
Roivant Sciences Ltd
11.22+0.01+0.09%
CYTK
Cytokinetics Inc
63.91+0.54+0.85%
ASND
Ascendis Pharma A/S
142.30+1.29+0.91%
PCVX
Vaxcyte Inc
63.73+0.02+0.03%